Blue Water Vaccines, Inc. Files Registration Statement for Initial Public Offering of Common Stock

Blue Water Vaccines, Inc. Announces Exclusive Rights to Patent Awarded to Oxford University Innovation Limited for the Development of a Universal Influenza Vaccine

- Blue Water Vaccines' licensing agreement with Oxford University Innovation Limited grants rights to technology developed by Oxford scientists

- Blue Water Vaccines will pay milestone payments to Oxford University Innovation Limited and royalties on sales subject to the achievement of key events

Blue Water Vaccines Announces the Appointment of Ronald R. Cobb as the Head of Science and Discovery

​

Blue Water Vaccines Announces Exclusive, Global License Agreement of Novel Versatile Vaccine Platform from Cincinnati Children's Hospital Medical Center

​

Blue Water Vaccines Announces the Appointments of Former Congressman Theodore S. Yoho as the Head of Business Development and Manufacturing Expert Andrew D. Skibo as the Global Head of Biologics Operations

​

Blue Water Vaccines Announces Development of Vaccine Candidates to Address G4 EA H1N1 Swine Influenza Virus and Streptococcus Pneumoniae

​

Blue Water Vaccines Licenses Patent Rights for Streptococcus Pneumoniae Vaccine Development from St. Jude Children's Research Hospital

​

Blue Water Vaccines, Developing Universal Flu Vaccine, to Partner With Ology Bioservices Inc.

​